Europe · Exchanges & live quotes · Boursier.com

bioMérieux : ventes solides au 3e trimestre, objectifs 2026 confirmés

Published by Boursier.com · France 17 h ago

(Boursier.com) — Le laboratoire bioMérieux, spécialiste du diagnostic in vitro, a enregistré un chiffre d'affaires de 1.042 millions d'euros pour son 3e trimestre 2026, affichant…

Read the full article on Boursier.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.boursier.com)

Also worth reading

Euronext

OPEC+ agrees in principle to keep oil output targets steady in December, sources say

London Stock Exchange Group

bioMérieux : ventes solides au 3e trimestre, objectifs 2026 confirmés

Share

Also worth reading

OPEC+ agrees in principle to keep oil output targets steady in December, sources say

LSEG to acquire Octus, creating market leader across public and private credit solutions